Top

Published in:

Open Access 01-12-2022 | Mood Disorders | Study protocol

Study protocol for pragmatic trials of Internet-delivered guided and unguided cognitive behavior therapy for treating depression and anxiety in university students of two Latin American countries: the Yo Puedo Sentirme Bien study

Authors: Corina Benjet, Ronald C. Kessler, Alan E. Kazdin, Pim Cuijpers, Yesica Albor, Nayib Carrasco Tapias, Carlos C. Contreras-Ibáñez, Ma Socorro Durán González, Sarah M. Gildea, Noé González, José Benjamín Guerrero López, Alex Luedtke, Maria Elena Medina-Mora, Jorge Palacios, Derek Richards, Alicia Salamanca-Sanabria, Nancy A. Sampson

Published in: Trials | Issue 1/2022

Abstract

Background

Major depressive disorder (MDD) and generalized anxiety disorder (GAD) are highly prevalent among university students and predict impaired college performance and later life role functioning. Yet most students do not receive treatment, especially in low-middle-income countries (LMICs). We aim to evaluate the effects of expanding treatment using scalable and inexpensive Internet-delivered transdiagnostic cognitive behavioral therapy (iCBT) among college students with symptoms of MDD and/or GAD in two LMICs in Latin America (Colombia and Mexico) and to investigate the feasibility of creating a precision treatment rule (PTR) to predict for whom iCBT is most effective.

Methods

We will first carry out a multi-site randomized pragmatic clinical trial (N = 1500) of students seeking treatment at student mental health clinics in participating universities or responding to an email offering services. Students on wait lists for clinic services will be randomized to unguided iCBT (33%), guided iCBT (33%), and treatment as usual (TAU) (33%). iCBT will be provided immediately whereas TAU will be whenever a clinic appointment is available. Short-term aggregate effects will be assessed at 90 days and longer-term effects 12 months after randomization. We will use ensemble machine learning to predict heterogeneity of treatment effects of unguided versus guided iCBT versus TAU and develop a precision treatment rule (PTR) to optimize individual student outcome. We will then conduct a second and third trial with separate samples (n = 500 per arm), but with unequal allocation across two arms: 25% will be assigned to the treatment determined to yield optimal outcomes based on the PTR developed in the first trial (PTR for optimal short-term outcomes for Trial 2 and 12-month outcomes for Trial 3), whereas the remaining 75% will be assigned with equal allocation across all three treatment arms.

Discussion

By collecting comprehensive baseline characteristics to evaluate heterogeneity of treatment effects, we will provide valuable and innovative information to optimize treatment effects and guide university mental health treatment planning. Such an effort could have enormous public-health implications for the region by increasing the reach of treatment, decreasing unmet need and clinic wait times, and serving as a model of evidence-based intervention planning and implementation.

Trial status

IRB Approval of Protocol Version 1.0; June 3, 2020. Recruitment began on March 1, 2021. Recruitment is tentatively scheduled to be completed on May 30, 2024.

Trial registration

ClinicalTrials.govNCT04780542. First submission date: February 28, 2021.

Auerbach RP, Alonso J, Axinn WG, Cuijpers P, Ebert DD, Green JG, et al. Mental disorders among college students in the World Health Organization World Mental Health Surveys. Psychol Med. 2016;46(14):2955–70. https://doi.org/10.1017/S0033291716001665.CrossRefPubMedPubMedCentral

Cuijpers P, Auerbach RP, Benjet C, Bruffaerts R, Ebert D, Karyotaki E, et al. Introduction to the special issue: The WHO World Mental Health International College Student (WMH-ICS) initiative. Int J Methods Psychiatr Res. 2019;28(2):e1762. https://doi.org/10.1002/mpr.1762.CrossRefPubMedPubMedCentral

Auerbach RP, Mortier P, Bruffaerts R, Alonso J, Benjet C, Cuijpers P, et al. Mental disorder comorbidity and suicidal thoughts and behaviors in the World Health Organization World Mental Health Surveys International College Student initiative. Int J Methods Psychiatr Res. 2019;28(2):e1752. https://doi.org/10.1002/mpr.1752.CrossRefPubMed

Alonso J, Vilagut G, Mortier P, Auerbach RP, Bruffaerts R, Cuijpers P, et al. The role impairment associated with mental disorder risk profiles in the WHO World Mental Health International College Student Initiative. Int J Methods Psychiatr Res. 2019;28(2):e1750. https://doi.org/10.1002/mpr.1750.CrossRefPubMed

Bruffaerts R, Mortier P, Auerbach RP, Alonso J, Hermosillo De la Torre AE, Cuijpers P, et al. Lifetime and 12-month treatment for mental disorders and suicidal thoughts and behaviors among first year college students. Int J Methods Psychiatr Res. 2019;28(2):e1764. https://doi.org/10.1002/mpr.1764.CrossRefPubMedPubMedCentral

Alonso J, Liu Z, Evans-Lacko S, Sadikova E, Sampson N, Chatterji S, et al. Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries. Depress Anxiety. 2018;35(3):195–208. https://doi.org/10.1002/da.22711.CrossRefPubMedPubMedCentral

Degenhardt L, Glantz M, Evans-Lacko S, Sadikova E, Sampson N, Thornicroft G, et al. Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys. World Psychiatry. 2017;16(3):299–307. https://doi.org/10.1002/wps.20457.CrossRefPubMedPubMedCentral

Thornicroft G, Chatterji S, Evans-Lacko S, Gruber M, Sampson N, Aguilar-Gaxiola S, et al. Undertreatment of people with major depressive disorder in 21 countries. Br J Psychiatry. 2017;210(2):119–24. https://doi.org/10.1192/bjp.bp.116.188078.CrossRefPubMedPubMedCentral

Evans-Lacko S, Thornicroft G. Viewpoint: WHO World Mental Health Surveys International College Student initiative: Implementation issues in low- and middle-income countries. Int J Methods Psychiatr Res. 2019;28(2):e17566. https://doi.org/10.1002/mpr.1756.CrossRef

10.

Mullan F, Frehywot S, Omaswa F, Buch E, Chen C, Greysen SR, et al. Medical schools in sub-Saharan Africa. Lancet. 2011;377(9771):1113–21. https://doi.org/10.1016/s0140-6736(10)61961-7.CrossRefPubMed

11.

Schendel R, McCowan T. Expanding higher education systems in low- and middle-income countries: the challenges of equity and quality. High Educ. 2016;72(4):407–11. https://doi.org/10.1007/s10734-016-0028-6.CrossRef

12.

Shamsuddin K, Fadzil F, Ismail WSW, Shah SA, Omar K, Muhammad NA, et al. Correlates of depression, anxiety and stress among Malaysian university students. Asian J Psychiatr. 2013;6(4):318–23. https://doi.org/10.1016/j.ajp.2013.01.014.CrossRefPubMed

13.

Ibrahim AK, Kelly SJ, Adams CE, Glazebrook C. A systematic review of studies of depression prevalence in university students. J Psychiatr Res. 2013;47(3):391–400. https://doi.org/10.1016/j.jpsychires.2012.11.015.CrossRefPubMed

14.

Brosnan C, Southgate E, Outram S, Lempp H, Wright S, Saxby T, et al. Experiences of medical students who are first in family to attend university. Med Educ. 2016;50(8):842–51. https://doi.org/10.1111/medu.12995.CrossRefPubMed

15.

Southgate E, Brosnan C, Lempp H, Kelly B, Wright S, Outram S, et al. Travels in extreme social mobility: how first-in-family students find their way into and through medical education. Crit Stud Educ. 2017;58(2):242–60. https://doi.org/10.1080/17508487.2016.1263223.CrossRef

16.

Stebleton MJ, Soria KM, Huesman RL Jr. First-generation students’ sense of belonging, mental health, and use of counseling services at public research universities. J Coll Couns. 2014;17(1):6–20. https://doi.org/10.1002/j.2161-1882.2014.00044.x.CrossRef

17.

Covarrubias R, Romero A, Trivelli M. Family achievement guilt and mental well-being of college students. J Child Fam Stud. 2015;24(7):2031–7. https://doi.org/10.1007/s10826-014-0003-8.CrossRef

18.

Hakim JG, Chidzonga MM, Borok MZ, Nathoo KJ, Matenga J, Havranek E, et al. Medical education partnership initiative (MEPI) in Zimbabwe: outcomes and challenges. Glob Health Sci Pract. 2018;6(1):82–92. https://doi.org/10.9745/ghsp-d-17-00052.CrossRefPubMedPubMedCentral

19.

Palacios JE, Richards D, Palmer R, Coudray C, Hofmann SG, Palmieri PA, et al. Supported internet-delivered cognitive behavioral therapy programs for depression, anxiety, and stress in university students: Open, non-randomised trial of acceptability, effectiveness, and satisfaction. JMIR Ment Health. 2018;5(4):e11467. https://doi.org/10.2196/11467.CrossRefPubMedPubMedCentral

20.

Arjadi R, Nauta MH, Chowdhary N, Bockting CLH. A systematic review of online interventions for mental health in low and middle income countries: a neglected field. Glob Ment Health. 2015;2:e12. https://doi.org/10.1017/gmh.2015.10.CrossRef

21.

Fu Z, Burger H, Arjadi R, Bockting CL. Effectiveness of digital psychological interventions for mental health problems in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Psychiatry. 2020;7(10):851–64. https://doi.org/10.1016/S2215-0366(20)30256-X.CrossRefPubMedPubMedCentral

22.

Jiménez-Molina Á, Franco P, Martínez V, Martínez P, Rojas G, Araya R. Internet-based interventions for the prevention and treatment of mental disorders in Latin America: a scoping review. Front Psychiatry. 2019;10:664. https://doi.org/10.3389/fpsyt.2019.00664.CrossRefPubMedPubMedCentral

23.

Harrer M, Adam SH, Baumeister H, Cuijpers P, Karyotaki E, Auerbach RP, et al. Internet interventions for mental health in university students: a systematic review and meta-analysis. Int J Methods Psychiatr Res. 2019;28(2):e1759. https://doi.org/10.1002/mpr.1759.CrossRefPubMed

24.

Harrer M, Adam SH, Fleischmann RJ, Baumeister H, Auerbach R, Bruffaerts R, et al. Effectiveness of an internet- and app-based intervention for college students with elevated stress: randomized controlled trial. J Med Internet Res. 2018;20(4):e136. https://doi.org/10.2196/jmir.9293.CrossRefPubMedPubMedCentral

25.

Salamanca-Sanabria A, Richards D, Timulak L, Connell S, Mojica-Perilla M, Parra-Villa Y, et al. A culturally adapted cognitive behavioral internet-delivered intervention for depressive symptoms: randomized controlled trial. JMIR Ment Health. 2020;6(12):1–20. https://doi.org/10.2196/13392.CrossRef

26.

Norton PJ, Roberge P. Transdiagnostic therapy. Psychiatr Clin North Am. 2017;40(4):675–87. https://doi.org/10.1016/j.psc.2017.08.003.CrossRefPubMed

27.

Richards D, Enrique A, Eilert N, Franklin M, Palacios J, Duffy D, et al. A pragmatic randomized waitlist-controlled effectiveness and cost-effectiveness trial of digital interventions for depression and anxiety. Digital Med. 2020;3:85. https://doi.org/10.1038/s41746-020-0293-8.CrossRef

28.

NIH National Institute of Mental Health. Strategic Objective 3. 2008. https://www.nimh.nih.gov/about/strategic-planning-reports/strategic-objective-3.shtml. Accessed 16 Sept. 2019.

29.

Maj M, Stein DJ, Parker G, Zimmerman M, Fava GA, De Hert M, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19(3):269–93. https://doi.org/10.1002/wps.20771.CrossRefPubMedPubMedCentral

30.

Pescosolido BA. Stigma as a mental health policy controversy: positions, options, and strategies for change. In: Goldman H, Frank R, Morrissey J, editors. The Palgrave Handbook of American Mental Health Policy. Cham: Palgrave Macmillan; 2020. p. 543–72. https://doi.org/10.1007/978-3-030-11908-9_19.CrossRef

31.

Luedtke AR, van der Laan MJ. Evaluating the impact of treating the optimal subgroup. Stat Methods Med Res. 2017;26(4):1630–40. https://doi.org/10.1177/0962280217708664.CrossRefPubMedPubMedCentral

32.

Kessler RC. The potential of predictive analytics to provide clinical decision support in depression treatment planning. Curr Opin Psychiatry. 2018;31(1):32–9. https://doi.org/10.1097/yco.0000000000000377.CrossRefPubMed

33.

Cohen ZD, DeRubeis RJ. Treatment selection in depression. Annu Rev Clin Psychol. 2018;14(1):209–36. https://doi.org/10.1146/annurev-clinpsy-050817-084746.CrossRefPubMed

34.

Karyotaki E, Efthimiou O, Miguel C, Bermpohl FMG, Furukawa TA, Cuijpers P, et al. Internet-based cognitive behavioral therapy for depression: a systematic review and individual patient data network meta-analysis. JAMA Psychiatry. 2021;78(4):361–71. https://doi.org/10.1001/jamapsychiatry.2020.4364.CrossRefPubMed

35.

Huguet A, Rao S, McGrath PJ, Wozney L, Wheaton M, Conrod J, et al. A systematic review of cognitive behavioral therapy and behavioral activation apps for depression. PLoS One. 2016;11(5):e0154248. https://doi.org/10.1371/journal.pone.0154248.CrossRefPubMedPubMedCentral

36.

Coull G, Morris PG. The clinical effectiveness of CBT-based guided self-help interventions for anxiety and depressive disorders: a systematic review. Psychol Med. 2011;41(11):2239–52. https://doi.org/10.1017/s0033291711000900.CrossRefPubMed

37.

Cuijpers P, Kleiboer A, Karyotaki E, Riper H. Internet and mobile interventions for depression: opportunities and challenges: Cuijpers et al. Depress Anxiety. 2017;34(7):596–602. https://doi.org/10.1002/da.22641.CrossRefPubMed

38.

Newman MG, Szkodny LE, Llera SJ, Przeworski A. A review of technology-assisted self-help and minimal contact therapies for anxiety and depression: Is human contact necessary for therapeutic efficacy? Clin Psychol Rev. 2011;31(1):89–103. https://doi.org/10.1016/j.cpr.2010.09.008.CrossRefPubMed

39.

Simmonds-Buckley M, Bennion MR, Kellett S, Millings A, Hardy GE, Moore RK. Acceptability and effectiveness of NHS-recommended e-therapies for depression, anxiety, and stress: meta-analysis. J Med Internet Res. 2020;22(10):e17049. https://doi.org/10.2196/17049.CrossRefPubMedPubMedCentral

40.

Duffy D, Enrique A, Connell S, Connolly C, Richards D. Internet-delivered cognitive behavior therapy as a prequel to face-to-face therapy for depression and anxiety: a naturalistic observation. Front Psychiatry. 2020;10:902. https://doi.org/10.3389/fpsyt.2019.00902.CrossRefPubMedPubMedCentral

41.

Enrique A, Palacios JE, Ryan H, Richards D. Exploring the relationship between usage and outcomes of an internet-based intervention for individuals with depressive symptoms: secondary analysis of data from a randomized controlled trial. J Med Internet Res. 2019;21(8):e12775. https://doi.org/10.2196/12775.CrossRefPubMedPubMedCentral

42.

Salamanca-Sanabria A, Richards D, Timulak L. Adapting an internet-delivered intervention for depression for a Colombian college student population: an illustration of an integrative empirical approach. Internet Interv. 2019;15:76–86. https://doi.org/10.1016/j.invent.2018.11.005.CrossRefPubMedPubMedCentral

43.

Bo Borghouts J, Eikey E, Mark G, De Leon C, Schueller SM, Schneider M, et al. Barriers to and facilitators of user engagement with digital mental health interventions: Systematic review. J Med Internet Res. 2021;23(3):e24387. https://doi.org/10.2196/24387.CrossRef

44.

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13. https://doi.org/10.1046/j.1525-1497.2001.016009606.x.CrossRefPubMedPubMedCentral

45.

Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006;166(10):1092–7. https://doi.org/10.1001/archinte.166.10.1092.CrossRefPubMed

46.

Kroenke K, Wu J, Yu Z, Bair MJ, Kean J, Stump T, et al. Patient health questionnaire anxiety and depression scale: Initial validation in three clinical trials. Psychosom Med. 2016;78(6):716–27. https://doi.org/10.1097/psy.0000000000000322.CrossRefPubMedPubMedCentral

47.

Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24–31. https://doi.org/10.1016/j.genhosppsych.2015.11.005.CrossRefPubMed

48.

McMillan D, Gilbody S, Richards D. Defining successful treatment outcome in depression using the PHQ-9: A comparison of methods. J Affect Disord. 2010;127(1–3):122–9. https://doi.org/10.1016/j.jad.2010.04.030.CrossRefPubMed

49.

Zimmerman M, Walsh E, Friedman M, Boerescu DA, Attiullah N. Identifying remission from depression on 3 self-report scales. J Clin Psychiatry. 2017;78(02):177–83. https://doi.org/10.4088/JCP.16m10641.CrossRefPubMed

50.

Sheehan DV, Mancini M, Wang J, Berggren L, Cao H, Dueñas HJ, et al. Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors. Hum Psychopharmacol. 2016;31(1):53–63. https://doi.org/10.1002/hup.2500.CrossRefPubMed

51.

Kessler RC, Calabrese JR, Farley PA, Gruber MJ, Jewell MA, Katon W, et al. Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders. Psychol Med. 2013;43(8):1625–37. https://doi.org/10.1017/s0033291712002334.CrossRefPubMed

52.

Kessler RC, Santiago PN, Colpe LJ, Dempsey CL, First MB, Heeringa SG, et al. Clinical reappraisal of the composite international diagnostic interview screening scales (CIDI-SC) in the army study to assess risk and resilience in servicemembers (army STARRS): Clinical reappraisal of the CIDI-SC in army STARRS. Int J Methods Psychiatr Res. 2013;22(4):303–21. https://doi.org/10.1002/mpr.1398.CrossRefPubMedPubMedCentral

53.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (5th ed.). Arlington: American Psychiatric Association; 2013.CrossRef

54.

Spitzer RL. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. JAMA. 1999;282(18):1737–44. https://doi.org/10.1001/jama.282.18.1737.CrossRefPubMed

55.

Zuromski KL, Ustun B, Hwang I, Keane TM, Marx BP, Stein MB, et al. Developing an optimal short-form of the PTSD Checklist for DSM-5 (PCL-5). Depress Anxiety. 2019;36(9):790–800. https://doi.org/10.1002/da.22942.CrossRefPubMedPubMedCentral

56.

Morin CM, Belleville G, Bélanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601–8. https://doi.org/10.1093/sleep/34.5.601.CrossRefPubMedPubMedCentral

57.

Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia–suicide severity rating scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266–77. https://doi.org/10.1176/appi.ajp.2011.10111704.CrossRefPubMedPubMedCentral

58.

Nock MK, Holmberg EB, Photos VI, Michel BD. Self-Injurious Thoughts and Behaviors Interview: development, reliability, and validity in an adolescent sample. Psychol Assess. 2007;19(3):309–17. https://doi.org/10.1037/1040-3590.19.3.309.CrossRefPubMed

59.

Luedtke A, Sadikova E, Kessler RC. Sample size requirements for multivariate models to predict between-patient differences in best treatments of major depressive disorder. Clin Psychol Sci. 2019;7(3):445–61. https://doi.org/10.1177/2167702618815466.CrossRef

60.

Kessler RC, van Loo HM, Wardenaar KJ, Bossarte RM, Brenner LA, Ebert DD, et al. Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder. Epidemiol Psychiatr Sci. 2017;26(1):22–36. https://doi.org/10.1017/S2045796016000020.CrossRefPubMed

61.

Driessen E, Hollon SD. Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators. Psychiatr Clin North Am. 2010;33(3):537–55. https://doi.org/10.1016/j.psc.2010.04.005.CrossRefPubMedPubMedCentral

62.

Schneider RL, Arch JJ, Wolitzky-Taylor KB. The state of personalized treatment for anxiety disorders: a systematic review of treatment moderators. Clin Psychol Rev. 2015;38:39–54. https://doi.org/10.1016/j.cpr.2015.02.004.CrossRefPubMed

63.

Jakubovski E, Bloch MH. Anxiety disorder-specific predictors of treatment outcome in the Coordinated Anxiety Learning and Management (CALM) Trial. Psychiatr Q. 2016;87(3):445–64. https://doi.org/10.1007/s11126-015-9399-6.CrossRefPubMed

64.

Webb CA, Rosso IM, Rauch SL. Internet-based cognitive-behavioral therapy for depression: current progress and future directions. Harv Rev Psychiatry. 2017;25(3):114–22. https://doi.org/10.1097/HRP.0000000000000139.CrossRefPubMedPubMedCentral

65.

Lowe B, Spitzer RL, Grafe K, Kroenke K, Quenter A, Zipfel S, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord. 2004;78(2):131–40. https://doi.org/10.1016/s0165-0327(02)00237-9.CrossRefPubMed

66.

Scott KM, Pd J, Stein DJ, Kessler RC, editors. Mental disorders around the world: facts and figures from the WHO World Mental Health Surveys. New York: Cambridge University Press; 2018. https://doi.org/10.1017/9781316336168.CrossRef

67.

Kessler RC, Akiskal HS, Angst J, Guyer M, Hirschfeld RMA, Merikangas KR, et al. Validity of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0. J Affect Disord. 2006;96(3):259–69. https://doi.org/10.1016/j.jad.2006.08.018.CrossRefPubMedPubMedCentral

68.

Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, Van Brunt DL. Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16(2):52–65. https://doi.org/10.1002/mpr.208.CrossRefPubMedPubMedCentral

69.

Kessler RC, Ustün TB. The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004;13(2):93–121. doi: 0.1002/mpr.168

70.

Norman CD, Skinner HA. EHEALS: the eHealth literacy scale. J Med Internet Res. 2006;8(4):e27. https://doi.org/10.2196/jmir.8.4.e27.CrossRefPubMedPubMedCentral

71.

Kessler RC, Hamilton L, Mickelson KD, Walters EE, Zhao S. Age and depression in the MIDUS survey. In: Brim OG, Ryff CD, Kessler RC, editors. How healthy are we? A national study of well-being at midlife. Chicago: University of Chicago Press; 2003. p. 227–51.

72.

Campbell-Sills L, Kessler RC, Ursano RJ, Sun X, Taylor CT, Heeringa SG, et al. Predictive validity and correlates of self-assessed resilience among U.S. Army soldiers. Depress Anxiety. 2018;35(2):122–31. https://doi.org/10.1002/da.22694.CrossRefPubMed

73.

Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the Connor-Davidson Resilience Scale (CD-RISC): validation of a 10-item measure of resilience. J Trauma Stress. 2007;20(6):1019–28. https://doi.org/10.1002/jts.20271.CrossRefPubMed

74.

Kelly PJ, Kyngdon F, Ingram I, Deane FP, Baker AL, Osborne BA. The Client Satisfaction Questionnaire-8: psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment: Client satisfaction in residential treatment. Drug Alcohol Rev. 2018;37(1):79–86. https://doi.org/10.1111/dar.12522.CrossRefPubMed

75.

Gupta S. Intention-to-treat concept: a review. Perspect Clin Res. 2011;2(3):109–12. https://doi.org/10.4103/2229-3485.83221.CrossRefPubMedPubMedCentral

76.

Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc. 1996;91(434):444–55. https://doi.org/10.1080/01621459.1996.10476902.CrossRef

77.

Wooldridge JM. Econometric analysis of cross section and panel data. Cambridge: MIT Press; 2002.

78.

Clarke PS, Windmeijer F. Instrumental variable estimators for binary outcomes. J Am Stat Assoc. 2012;107(500):1638–52. https://doi.org/10.1080/01621459.2012.734171.CrossRef

79.

Baiocchi M, Cheng J, Small DS. Instrumental variable methods for causal inference: Instrumental variable methods for causal inference. Stat Med. 2014;33(13):2297–340. https://doi.org/10.1002/sim.6128.CrossRefPubMedPubMedCentral

80.

Robins JM, Rotnitzky A, Zhao LP. Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assoc. 1994;89(427):846–66. https://doi.org/10.1080/01621459.1994.10476818.CrossRef

81.

Schnitzer ME, Lok JJ, Gruber S. Variable selection for confounder control, flexible modeling and Collaborative Targeted minimum loss-based estimation in causal inference. Int J Biostat. 2016;12(1):97–115. https://doi.org/10.1515/ijb-2015-0017.CrossRefPubMed

82.

Robins JM, Rotnitzky A. Recovery of information and adjustment for dependent censoring using surrogate markers. In: Jewell NP, Dietz K, Farewell VT, editors. AIDS Epidemiology: Methodological Issues. Boston: Birkhäuser Boston; 1992. p. 297–331. https://doi.org/10.1007/978-1-4757-1229-2_14.CrossRef

83.

Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55. https://doi.org/10.2307/2335942.CrossRef

84.

Faraway JJ. Extending the linear model with R: generalized linear, mixed effects and nonparametric regression models. 2nd ed. Boca Raton, FL: CRC Press; 2016. https://doi.org/10.1201/9781315382722.CrossRef

85.

Bunouf P, Molenberghs G. Implementation of pattern-mixture models in randomized clinical trials. Pharm Stat. 2016;15(6):494–506. https://doi.org/10.1002/pst.1780.CrossRefPubMed

86.

Stroup WW. Generalized linear mixed models: modern concepts, methods and applications. Boca Raton: CRC Press; 2013.

87.

Daniels MJ, Jackson D, Feng W, White IR. Pattern mixture models for the analysis of repeated attempt designs. Biometrics. 2015;71(4):1160–7. https://doi.org/10.1111/biom.12353.CrossRefPubMedPubMedCentral

88.

Kessler RC, Bossarte RM, Luedtke A, Zaslavsky AM, Zubizarreta JR. Machine learning methods for developing precision treatment rules with observational data. Behav Res Ther. 2019;120:103412. https://doi.org/10.1016/j.brat.2019.103412.CrossRefPubMedPubMedCentral

89.

VanderWeele TJ, Luedtke AR, van der Laan MJ, Kessler RC. Selecting optimal subgroups for treatment using many covariates. Epidemiology. 2019;30(3):334–41. https://doi.org/10.1097/ede.0000000000000991.CrossRefPubMedPubMedCentral

90.

Kessler RC, Bernecker SL, Bossarte RM, Luedtke AR, McCarthy JF, Nock MK, et al. The role of big data analytics in predicting suicide. In: Passos IC, Mwangi B, Kapczinski F, editors. Personalized Psychiatry: Big Data Analytics in Mental Health. Cham, Switzerland: Springer Nature Switzerland; 2019. p. 77–98. https://doi.org/10.1007/978-3-030-03553-2_5.CrossRef

91.

Kessler RC, Bossarte RM, Luedtke A, Zaslavsky AM, Zubizarreta JR. Suicide prediction models: a critical review of recent research with recommendations for the way forward. Mol Psychiatry. 2020;25(1):168–79. https://doi.org/10.1038/s41380-019-0531-0.CrossRefPubMed

92.

van der Laan MJ, Polley EC, Hubbard AE. Super learner. Stat Appl Genet Mol Biol. 2007;6(25). https://doi.org/10.2202/1544-6115.1309.

93.

DeRubeis RJ, Cohen ZD, Forand NR, Fournier JC, Gelfand LA, Lorenzo-Luaces L. The personalized advantage index: translating research on prediction into individualized treatment recommendations. A demonstration. PLoS One. 2014;9(1):e83875. https://doi.org/10.1371/journal.pone.0083875.CrossRefPubMed

94.

Luedtke AR, van der Laan MJ. Super-learning of an optimal dynamic treatment rule. Int J Biostat. 2016;12(1):305–32. https://doi.org/10.1515/ijb-2015-0052.CrossRefPubMed

95.

Luedtke A, Chambaz A. Faster rates for policy learning. 2017. Retrieved from: https://arxiv.org/abs/1704.06431.

96.

van Der Laan MJ, Rubin D. Targeted maximum likelihood learning. Int J Biostat. 2006;2(1): doi: 10.2202/1557-4679.1043.

97.

Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, for the CONSORT NPT Group. CONSORT statement for randomized trials of nonpharmacologic treatments: A 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40. https://doi.org/10.7326/M17-0046.CrossRefPubMed

98.

NIH National Institute of Mental Health. Policy Governing Independent Safety Monitors and Independent Data and safety monitoring boards. 2015. https://www.nimh.nih.gov/funding/clinical-research/policy-governing-independent-safety-monitors-and-independent-data-and-safety-monitoring-boards.shtml. Accessed 16 Sept 2019.

99.

Kazdin AE. Technology-based interventions and reducing the burdens of mental illness: perspectives and comments on the special series. Cogn Behav Pract. 2015;22(3):359e66–366. https://doi.org/10.1016/j.cbpra.2015.04.004.CrossRef

100.

Gulliver A, Calear AL, Sunderland M, Kay-Lambkin F, Farrer LM, Batterham PJ. Predictors of acceptability and engagement in a self-guided online program for depression and anxiety. Internet Interv. 2021;100400:100400. https://doi.org/10.1016/j.invent.2021.100400.CrossRef

101.

Simon N, McGillivray L, Roberts NP, Barawi K, Lewis CE, Bisson JI. Acceptability of internet-based cognitive behavioural therapy (i-CBT) for post-traumatic stress disorder (PTSD): a systematic review. Eur J Psychotraumatol. 2019;10(1):1646092. https://doi.org/10.1080/20008198.2019.1646092.CrossRefPubMedPubMedCentral

Title: Study protocol for pragmatic trials of Internet-delivered guided and unguided cognitive behavior therapy for treating depression and anxiety in university students of two Latin American countries: the Yo Puedo Sentirme Bien study
Authors: Corina Benjet
Ronald C. Kessler
Alan E. Kazdin
Pim Cuijpers
Yesica Albor
Nayib Carrasco Tapias
Carlos C. Contreras-Ibáñez
Ma Socorro Durán González
Sarah M. Gildea
Noé González
José Benjamín Guerrero López
Alex Luedtke
Maria Elena Medina-Mora
Jorge Palacios
Derek Richards
Alicia Salamanca-Sanabria
Nancy A. Sampson
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Mood Disorders
Affective Disorder
Anxiety
Published in: Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-022-06255-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Study protocol for pragmatic trials of Internet-delivered guided and unguided cognitive behavior therapy for treating depression and anxiety in university students of two Latin American countries: the Yo Puedo Sentirme Bien study

Abstract

Background

Methods

Discussion

Trial status

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Discussion

Trial status

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2022

Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial

Third-generation cognitive behavioral therapy versus treatment-as-usual for attention deficit and hyperactivity disorder: a multicenter randomized controlled trial

Correction to: Hearing dogs for people with severe and profound hearing loss: a wait-list design randomised controlled trial investigating their effectiveness and cost-effectiveness

Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial

TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II–III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis

Proper understanding of recurrent stress urinary incontinence treatment in women (PURSUIT): a randomised controlled trial of endoscopic and surgical treatment